p53 overexpression in nasopharyngeal carcinoma

In Vivo

Volumn 18, Issue 5, 2004, Pages 555-560

  Agaoglu, Fulya Yaman ^a   Dizdar, Yavuz ^a   Dogan, Oner ^a   Alatli, Canan ^b   Ayan, Inci ^b   Savci, Nejat ^b   Tas, Siirsel ^a   Dalay, Nejat ^b   Altun, Musa ^a  

^a ISTANBUL UNIVERSITY   (Turkey)

^b ISTANBUL UNIVERSITY   (Turkey)

Author keywords

Nasopharyngeal carcinoma; p53

Indexed keywords

PARAFFIN; PROTEIN P53;

ADOLESCENT; ADULT; AGE DISTRIBUTION; AGED; ARTICLE; CANCER STAGING; CANCER SURVIVAL; CANCER TISSUE; CARCINOGENESIS; CERVICAL LYMPH NODE; CHI SQUARE TEST; CLINICAL FEATURE; CLINICAL OBSERVATION; CONTROLLED STUDY; CORRELATION COEFFICIENT; DISEASE ASSOCIATION; FEMALE; GENE OVEREXPRESSION; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IMMUNOREACTIVITY; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; NASOPHARYNX CARCINOMA; SCHOOL CHILD; SEX DIFFERENCE; STATISTICAL ANALYSIS; TISSUE SECTION; TREATMENT OUTCOME; TUMOR BIOPSY;

EID: 6944243898     PISSN: 0258851X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (29)

1. Altun M, Fandi A, Dupuis O, Cvitcovic E, Krajina Z and Eschwege F: Undifferantiated nasopharyngeal cancer (UCNT): Current diagnostic and therapeutic aspects. Int J Radiat Biol Phys 32: 859-877, 1995.
2. Joab I, Nicholas JC and Schwaab G: Detection of anti-Epstein Barr virus transactivator (ZEBRA) antibodies in sera from patients with nasopharyngeal carcinoma. Int J Cancer 48: 647-649, 1991.
3. Niedobiteck G, Aganthanggelou A, Barber P, Smallman LA, Jones EL and Young LS: P53 overexpression and Epstein Barr virus infection in undifferentiated squamous cell nasopharyngeal carcinomas. J Pathol 170 457-461, 1993.
4. Liu FF and O'Sullivan B: In regard to Su and Wang: prognostic value of Chinese race in nasopharyngeal cancer. Int J Radiat Oncol Biol Phys 54: 752-758, 2002.
5. Raab-Traub N: Epstein-Barr virus in the pathogenesis of NPC. Semin Cancer Biol 12: 431-441, 2002.
6. Curtis C, Harris MD and Holstein M: Clinical aplications of the p53 tumor supressor gene. N Engl J Med 329: 1318-1327, 1993.
7. Effert P, McCoy R, Abdel-Hamid M, Flynn M, Zhang Q, Busson P, Turz T, Liu E and Rab-Traub N: Alterations of the p53 gene in nasopharyngeal carcinomas. J Virol 66: 3768-3775, 1992.
8. Gallo O, Bianchi S, Uzzielli MLG, Santaro R, Lenzi S, Salimbeni C, Abruzzese M and Alajmo E: p53 oncoprotein overexpression correlates with mutagen induced chromosome fragility in head and neck cancer patients with multiple malignancies. Br J Cancer 71: 1008-1012, 1995.
9. Levine AJ, Perry ME, Chang A et al: The 1993 Walter Hupert Lecture-The role of the p53 tumor suppressor gene in tumorigenesis. Br J Cancer 69: 409-416, 1994.
10. Maltzmann W and Czyzyk L: UV irradiation stimulates levels of p53 cellular tumor antigen in nontransformed mouse cells. Mol Cell Biol 4: 1689-1694, 1984.
11. Levine AJ, Momand J and Finley CA: The p53 tumor suppresor gene. Nature 351: 453-456, 1991.
12. Levine AJ: The p53 tumor suppressor gene and product. Cancer Surv 12: 59-79, 1992.
13. Shin DM, Lee JS, Lipmann SM, Lee JJ, Tu N, Choi G, Heyne K, Shin HJC, Ro JY, Goepfert H, Hong WK and Hittelman WN: p53 expression: Predicting recurrence and second primary tumors in head and neck squamous cell carcinoma. J Natl Cancer Inst 88: 519-529, 1996.
14. Wai Lo K and Huang DP: Genetic and epigenetic changes in nasopharyngeal carcinoma. Semin Cancer Biol 12: 451-462, 2002.
15. Porter MJ, Field JK, Lee JCK, Leung SF, Lo D and Van Hasselt CA: Detection of the tumor suppressor gene p53 in nasopharyngeal carcinoma in Hong Kong Chinese. Anticancer Res 14: 1357-1360, 1994.
16. Sun Y, Hegamyer G, Cheng YJ, Hildesheim A, Chen JY, Chen IH, Cao Y and Collbrun NH: An infrequent mutation of the p53 gene in human nasopharyngeal carcinoma. Proc Natl Acad Sci 89:6516-6520, 1992.
17. Lo KW, Mok CH, Huang DP, Liu YX, Choi PHK, Lee JCK and Tsao SW: p53 mutation in human nasopharyngeal carcinomas. Anticancer Res 12 1957-1964, 1992.
18. International Histological Classification of Tumors, No 19: Histological Typing of Upper Respiratory Tract Tumors. World Health Organisation 32, Geneve, 1978.
19. American Joint Committee on Cancer (AJCC) Cancer Staging Manual 4th edition Philadelphia JB; Lippincott (1992), page 33.
20. Miller KD, Singh H and Waterspoon AC: Current trends in immunocytochemistry. Progress Pathol 1: 114-115,1995.
21. Ayan I, Luca JW, Jaffe N, Strong LC and Hansen MF: De novo germline mutations of the p53 gene in young children with sarcomas. Oncology Rep 4: 679-683, 1997.
22. Maity A, Kao GD, Muschel RJ and McKenna G: Potential moleculer targets for manipulating the radiation response. Int J Radiat Oncol Biol Phys 37: 639-653, 1997.
23. Sheu LF, Chen A, Tseng HH, Leu FJ, Lin JK, Ho KC and Meng CL: Assesment of p53 expression in nasopharyngeal carcinoma. Human Pathol 26: 380-386, 1995.
24. Greenblatt MS, Bennett WP, Holstein M and Harris CC: Mutations in the p53 tumor suppressor gene: clues to cancer etiology and moleculer pathogenesis. Cancer Res 54: 4855-4878, 1994.
25. Wang LD, Hong JY, Qiu SL et al: Accumulation of p53 protein in human esophageal precancerous lesions: A possible biomarker for carcinogenesis. Cancer Res 53: 1783-1787, 1993.
26. Masuda M, Shinokuma A, Hirakawa N, Nakashima T and Komiyama S: Expression of bcl-2, p53, and Ki-67 and outcome of patients with primary nasopharyngeal carcinomas following DNA-damaging treatment. Head Neck 20: 640-644, 1998.
27. Li JH, Lax SA, Kim J, Klamut H and Liu FF: The effects of combining ionizing radiation and adenoviral p53 therapy in nasopharyngeal carcinoma. Int J Radiat Oncol Biol Phys 43: 607-616, 1999.
28. Liu FF: Novel gene therapy approach for nasopharyngeal carcinoma: Semin Cancer Biol 12: 505-515, 2002.
29. Lax SA, Chia MC, Busson P, Klamut HJ and Liu FF: Adenovirus-p53 gene therapy in human nasopharyngeal carcinoma xenografts. Radiother Oncol 61: 309-312, 2001.